{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:54:00Z","timestamp":1791910440283,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFA0107400"],"award-info":[{"award-number":["2018YFA0107400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.yjmcc.2021.06.013","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T23:18:58Z","timestamp":1625267938000},"page":"27-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"special_numbering":"C","title":["FNDC5\/Irisin attenuates diabetic cardiomyopathy in a type 2 diabetes mouse model by activation of integrin \u03b1V\/\u03b25-AKT signaling and reduction of oxidative\/nitrosative stress"],"prefix":"10.1016","volume":"160","author":[{"given":"Chen","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congye","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huishou","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhe","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2021.06.013_bb0005","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9(th) edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"1","key":"10.1016\/j.yjmcc.2021.06.013_bb0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12933-018-0763-3","article-title":"Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies","volume":"17","author":"Kaur","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"issue":"4","key":"10.1016\/j.yjmcc.2021.06.013_bb0015","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4239\/wjd.v5.i4.444","article-title":"Type 2 diabetes and cardiovascular disease: have all risk factors the same strength?","volume":"5","author":"Mart\u00edn-Tim\u00f3n","year":"2014","journal-title":"World J. Diabetes"},{"issue":"6","key":"10.1016\/j.yjmcc.2021.06.013_bb0020","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.yjmcc.2021.06.013_bb0025","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pharmthera.2014.01.003","article-title":"Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways","volume":"142","author":"Huynh","year":"2014","journal-title":"Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.yjmcc.2021.06.013_bb0030","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","article-title":"Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence","volume":"17","author":"Tan","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"3","key":"10.1016\/j.yjmcc.2021.06.013_bb0035","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41401-020-0461-z","article-title":"Zonisamide, an antiepileptic drug, alleviates diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress","volume":"42","author":"Tian","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.yjmcc.2021.06.013_bb0040","doi-asserted-by":"crossref","first-page":"142191","DOI":"10.1016\/j.scitotenv.2020.142191","article-title":"MALAT1-mediated recruitment of the histone methyltransferase EZH2 to the microRNA-22 promoter leads to cardiomyocyte apoptosis in diabetic cardiomyopathy","volume":"766","author":"Wang","year":"2021","journal-title":"Sci. Total Environ."},{"issue":"1","key":"10.1016\/j.yjmcc.2021.06.013_bb0045","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.mayocp.2019.07.008","article-title":"Diabetes mellitus is an independent predictor for the development of heart failure: a population study","volume":"95","author":"Klajda","year":"2020","journal-title":"Mayo Clin. Proc."},{"issue":"5","key":"10.1016\/j.yjmcc.2021.06.013_bb0050","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jacc.2018.11.033","article-title":"Heart failure with preserved ejection fraction and diabetes: JACC state-of-the-art review","volume":"73","author":"McHugh","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.yjmcc.2021.06.013_bb0055","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/CIRCULATIONAHA.116.024593","volume":"135","author":"Kristensen","year":"2017","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.yjmcc.2021.06.013_bb0060","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/eurheartj\/ehq426","article-title":"Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment","volume":"32","author":"Borlaug","year":"2011","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.yjmcc.2021.06.013_bb0065","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12471-016-0815-9","article-title":"Animal models of heart failure with preserved ejection fraction","volume":"24","author":"Conceicao","year":"2016","journal-title":"Neth. Hear. J."},{"issue":"6","key":"10.1016\/j.yjmcc.2021.06.013_bb0070","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11906-008-0084-0","article-title":"Impaired cardiac function in leptin-deficient mice","volume":"10","author":"Ren","year":"2008","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.yjmcc.2021.06.013_bb0075","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.peptides.2014.03.021","article-title":"Three new players in energy regulation: preptin, adropin and irisin","volume":"56","author":"Aydin","year":"2014","journal-title":"Peptides"},{"issue":"7382","key":"10.1016\/j.yjmcc.2021.06.013_bb0080","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature10777","article-title":"A PGC1-\u03b1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis","volume":"481","author":"Bostr\u00f6m","year":"2012","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.yjmcc.2021.06.013_bb0085","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2337\/db13-1106","article-title":"Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling","volume":"63","author":"Zhang","year":"2014","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.yjmcc.2021.06.013_bb0090","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/s41401-019-0230-z","article-title":"Irisin exerts a therapeutic effect against myocardial infarction via promoting angiogenesis","volume":"40","author":"Liao","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.yjmcc.2021.06.013_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.166","article-title":"Irisin attenuates myocardial ischemia\/reperfusion-induced cardiac dysfunction by regulating ER-mitochondria interaction through a mitochondrial ubiquitin ligase-dependent mechanism","volume":"10","author":"Lu","year":"2020","journal-title":"Clin. Transl. Med."},{"issue":"5","key":"10.1016\/j.yjmcc.2021.06.013_bb0100","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1042\/CS20190016","article-title":"FNDC5\/Irisin inhibits pathological cardiac hypertrophy","volume":"133","author":"Yu","year":"2019","journal-title":"Clin. Sci. (Lond.)"},{"issue":"2","key":"10.1016\/j.yjmcc.2021.06.013_bb0105","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.atherosclerosis.2015.10.020","article-title":"Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-null diabetic mice","volume":"243","author":"Lu","year":"2015","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.yjmcc.2021.06.013_bb0110","article-title":"Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts","volume":"6","author":"Mizuno","year":"2018","journal-title":"Phys. Rep."},{"issue":"13","key":"10.1016\/j.yjmcc.2021.06.013_bb0115","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.7150\/thno.33684","article-title":"Targeting mitochondrial dynamics by regulating Mfn2 for therapeutic intervention in diabetic cardiomyopathy","volume":"9","author":"Hu","year":"2019","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.yjmcc.2021.06.013_bb0120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13287-020-01602-0","article-title":"Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts","volume":"11","author":"Guan","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"10.1016\/j.yjmcc.2021.06.013_bb0125","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00395-013-0329-1","article-title":"Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK-PGC-1\u03b1 signaling contributing to increased vulnerability in diabetic heart","volume":"108","author":"Yan","year":"2013","journal-title":"Basic Res. Cardiol."},{"issue":"3","key":"10.1016\/j.yjmcc.2021.06.013_bb0130","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/ijo.2015.199","article-title":"Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the AMPK signaling pathway","volume":"40","author":"Xin","year":"2016","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.yjmcc.2021.06.013_bb0135","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yjmcc.2015.07.015","article-title":"Irisin improves endothelial function in type 2 diabetes through reducing oxidative\/nitrative stresses","volume":"87","author":"Zhu","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"17","key":"10.1016\/j.yjmcc.2021.06.013_bb0140","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1089\/ars.2015.6293","article-title":"Mitochondrial dynamics in diabetic cardiomyopathy","volume":"22","author":"Galloway","year":"2015","journal-title":"Antioxid. Redox Signal."},{"issue":"7","key":"10.1016\/j.yjmcc.2021.06.013_bb0145","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.cell.2018.10.025","article-title":"Irisin mediates effects on bone and fat via \u03b1V integrin receptors","volume":"175","author":"Kim","year":"2018","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.yjmcc.2021.06.013_bb0150","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41418-019-0372-z","article-title":"FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT","volume":"27","author":"Zhang","year":"2020","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.yjmcc.2021.06.013_bb0155","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.yjmcc.2021.06.013_bb0160","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41569-021-00511-w","article-title":"Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases","volume":"18","author":"Ren","year":"2021","journal-title":"Nat Rev Cardiol."},{"issue":"1","key":"10.1016\/j.yjmcc.2021.06.013_bb0165","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","article-title":"Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease","volume":"61","author":"Jia","year":"2018","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.yjmcc.2021.06.013_bb0170","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.2337\/diabetes.48.10.2059","article-title":"Metformin but not glyburide prevents high glucose-induced abnormalities in relaxation and intracellular Ca2+ transients in adult rat ventricular myocytes","volume":"48","author":"Ren","year":"1999","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.yjmcc.2021.06.013_bb0175","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jdiacomp.2013.03.002","article-title":"Lower circulating irisin is associated with type 2 diabetes mellitus","volume":"27","author":"Liu","year":"2013","journal-title":"J. Diabetes Complicat."},{"issue":"3","key":"10.1016\/j.yjmcc.2021.06.013_bb0180","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/apha.12421","article-title":"Metformin promotes irisin release from murine skeletal muscle independently of AMP-activated protein kinase activation","volume":"213","author":"Li","year":"2015","journal-title":"Acta Physiol. (Oxford, England)"},{"issue":"10","key":"10.1016\/j.yjmcc.2021.06.013_bb0185","first-page":"1850","article-title":"PGC-1 mediates the regulation of metformin in muscle irisin expression and function","volume":"7","author":"Yang","year":"2015","journal-title":"Am. J. Transl. Res."},{"issue":"5","key":"10.1016\/j.yjmcc.2021.06.013_bb0190","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1113\/jphysiol.2013.264655","article-title":"Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies","volume":"592","author":"Kurdiova","year":"2014","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.yjmcc.2021.06.013_bb0195","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0026-0495(00)90588-2","article-title":"The db\/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding","volume":"49","author":"Kobayashi","year":"2000","journal-title":"Metab. Clin. Exp."},{"issue":"4","key":"10.1016\/j.yjmcc.2021.06.013_bb0200","doi-asserted-by":"crossref","first-page":"H934","DOI":"10.1152\/ajpheart.00238.2018","article-title":"Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction","volume":"315","author":"Alex","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"8","key":"10.1016\/j.yjmcc.2021.06.013_bb0205","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.cardfail.2019.05.007","article-title":"Type 2 diabetes mellitus and heart failure, a scientific statement from the American heart association and heart failure society of America","volume":"25","author":"Dunlay","year":"2019","journal-title":"J. Card. Fail."},{"issue":"12","key":"10.1016\/j.yjmcc.2021.06.013_bb0210","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/01.RES.87.12.1123","article-title":"Myocardial cell death in human diabetes","volume":"87","author":"Frustaci","year":"2000","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.yjmcc.2021.06.013_bb0215","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1089\/152308603770380034","article-title":"Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes","volume":"5","author":"Sabri","year":"2003","journal-title":"Antioxid. Redox Signal."},{"issue":"8","key":"10.1016\/j.yjmcc.2021.06.013_bb0220","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1745-7254.2005.00146.x","article-title":"Oxidative stress and stress signaling: menace of diabetic cardiomyopathy","volume":"26","author":"Wold","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"issue":"7752","key":"10.1016\/j.yjmcc.2021.06.013_bb0225","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","article-title":"Nitrosative stress drives heart failure with preserved ejection fraction","volume":"568","author":"Schiattarella","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.yjmcc.2021.06.013_bb0230","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/path.4113","article-title":"Oxidative stress and myocardial injury in the diabetic heart","volume":"229","author":"Ansley","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.yjmcc.2021.06.013_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2017.06.010","article-title":"Role of CaMKII in free fatty acid\/hyperlipidemia-induced cardiac remodeling both in vitro and in vivo","volume":"109","author":"Zhong","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"6","key":"10.1016\/j.yjmcc.2021.06.013_bb0240","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ceca.2009.03.012","article-title":"Role of cardiolipin peroxidation and Ca2+ in mitochondrial dysfunction and disease","volume":"45","author":"Paradies","year":"2009","journal-title":"Cell Calcium"},{"key":"10.1016\/j.yjmcc.2021.06.013_bb0245","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3389\/fphar.2019.00998","article-title":"C arvacrol attenuates diabetic cardiomyopathy by modulating the PI3K\/AKT\/GLUT4 pathway in diabetic mice","volume":"10","author":"Hou","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"21","key":"10.1016\/j.yjmcc.2021.06.013_bb0250","doi-asserted-by":"crossref","first-page":"12355","DOI":"10.1111\/jcmm.15725","article-title":"Curcumin alleviates oxidative stress and inhibits apoptosis in diabetic cardiomyopathy via Sirt1-Foxo1 and PI3K-Akt signalling pathways","volume":"24","author":"Ren","year":"2020","journal-title":"J. Cell. Mol. Med."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282821001358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282821001358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T06:00:47Z","timestamp":1762668047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282821001358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":50,"alternative-id":["S0022282821001358"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2021.06.013","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FNDC5\/Irisin attenuates diabetic cardiomyopathy in a type 2 diabetes mouse model by activation of integrin \u03b1V\/\u03b25-AKT signaling and reduction of oxidative\/nitrosative stress","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2021.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}